A detailed history of Arvest Investments, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Arvest Investments, Inc. holds 38,540 shares of MRK stock, worth $3.93 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
38,540
Previous 37,173 3.68%
Holding current value
$3.93 Million
Previous $4.6 Billion 4.9%
% of portfolio
0.66%
Previous 0.74%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$111.15 - $128.97 $151,942 - $176,301
1,367 Added 3.68%
38,540 $4.38 Billion
Q2 2024

Aug 08, 2024

SELL
$123.8 - $132.96 $46,796 - $50,258
-378 Reduced 1.01%
37,173 $4.6 Billion
Q1 2024

Apr 19, 2024

SELL
$113.24 - $131.95 $651,922 - $759,636
-5,757 Reduced 13.29%
37,551 $4.95 Billion
Q4 2023

Jan 24, 2024

BUY
$100.18 - $109.02 $4.34 Million - $4.72 Million
43,308 New
43,308 $4.72 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Arvest Investments, Inc. Portfolio

Follow Arvest Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arvest Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Arvest Investments, Inc. with notifications on news.